IndiaMART InterMESH Discloses BRSR for FY 2025-26
IndiaMART InterMESH Limited has informed the NSE about its Business Responsibility and Sustainability Report forming part of the Integrated Annual Report for FY 2025-26.
Read articleAI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.
1,293 articles published
Results for “BI” · in Market Updates — Clear filters
IndiaMART InterMESH Limited has informed the NSE about its Business Responsibility and Sustainability Report forming part of the Integrated Annual Report for FY 2025-26.
Read articleUpdates Concord Biotech Limited has informed the Exchange regarding Abbreviated New Drug Application (ANDA) Approval for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL'. Concord Biotech Limited has informed the Exchange regarding Abbreviated New Drug Application (ANDA) Approval for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL'.
Read articleUpdates Concord Biotech Limited has informed the Exchange regarding Abbreviated New Drug Application (ANDA) Approval for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL'. Concord Biotech Limited has informed the Exchange regarding Abbreviated New Drug Application (ANDA) Approval for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL'.
Read articleUpdater Services Limited has announced the resignation of Mr. Subinder Jeet Singh Khurana as Independent Director from its material subsidiary, Denave India Private Limited.
Read articleCompany Update We are pleased to inform that the Company has received approval from USFDA for its ANDA for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL. We are pleased to inform that the Company has received approval from USFDA for its ANDA for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL.
Read articleCompany Update We are pleased to inform that the Company has received approval from USFDA for its ANDA for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL. We are pleased to inform that the Company has received approval from USFDA for its ANDA for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL.
Read articleCompany Update ✨ Investors Presentation is published - BSE✨: ✨ Investors Presentation is published - BSE✨: Pursuant to Regulation 30 of SEBI (LODR), Regulations, 2015, please find enclosed herewith copy of the Investor Presentation to be made at the Investor Meeting scheduled to be held on 4th June, 2026.
Read articleUpdater Services Limited has announced the resignation of Independent Director Subinder Jeet Singh Khurana from Denave India Private Limited, a material subsidiary. The disclosure was made under SEBI regulations.
Read articleGeneral Updates Indiamart Intermesh Limited has informed the Exchange about Business Responsibility and Sustainability Report forming part of the Integrated Annual Report of the Company for FY 2025-26. Indiamart Intermesh Limited has informed the Exchange about Business Responsibility and Sustainability Report forming part of the Integrated Annual Report of the Company for FY 2025-26.
Read articleGeneral Updates Indiamart Intermesh Limited has informed the Exchange about Business Responsibility and Sustainability Report forming part of the Integrated Annual Report of the Company for FY 2025-26. Indiamart Intermesh Limited has informed the Exchange about Business Responsibility and Sustainability Report forming part of the Integrated Annual Report of the Company for FY 2025-26.
Read articleGlobe Civil Projects has disclosed an inadvertent typographical error in its FY2026 consolidated financial filing submitted to the Stock Exchange on May 30, 2026.
Read articleGlobe Civil Projects has informed BSE that a typographical error was identified in the Consolidated Statement of Assets and Liabilities part of its FY2026 audited financial results.
Read articleGlobe Civil Projects has disclosed a typographical error in its consolidated financial results for the fiscal year ended March 31, 2026, submitted to the stock exchange on May 30, 2026.
Read articleNSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.
Filings and alerts in WhatsApp or Telegram
Focus on news that matter most to you
Track 5 companies at no cost. Upgrade anytime.